Document is current

Any future updates will be listed below

Combination chemotherapy with irinotecan and gemcitabine for taxane/platinum-resistant/refractory ovarian and primary peritoneal cancer: a multicenter phase I/II trial (GOGO-Ov 6)

Crossref DOI link: https://doi.org/10.1007/s00280-017-3468-5

Published Online: 2017-10-28

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark